Dyve Biosciences
Tatyana Beldock has 20+ years of operating and financial experience in healthcare. She has worked with companies at all stages, from startup (as a founder & CEO, board member, venture capitalist, investor, and advisor) to working as a senior executive at Fortune 50 leaders including Johnson & Johnson and Pfizer in addition to her financial roots (wall street research, bay area venture capital). Her track record includes 32 transactions exceeding $24B in value across biotech, health tech, medical devices, and financials.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Dyve Biosciences
1 followers
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.